| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067792A2 Inhibitory antibodies of HER3 activity |
| 06/10/2009 | EP2067791A1 Prophylactic or therapeutic agent for cancer |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067789A1 Anti-P selectin antibodies |
| 06/10/2009 | EP2067788A2 Fab fragment libraries and methods for their use |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067486A1 Use of CD23 antagonists for the treatment of neoplastic disorders |
| 06/10/2009 | EP2067472A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/10/2009 | EP2067044A1 Anti-drug antibody assay |
| 06/10/2009 | EP2066696A1 Anti-cancer antibodies against lewisy and lewisb antigens |
| 06/10/2009 | EP2066695A2 Anti-myostatin antibodies |
| 06/10/2009 | EP2066694A2 Compositions and methods for diagnosing and treating cancer |
| 06/10/2009 | EP2066354A1 Norovirus vaccine formulations |
| 06/10/2009 | EP2066353A1 Combination of zd6474 and bevacizumab for cancer therapy |
| 06/10/2009 | EP2066352A1 Treatment of multiple sclerosis (ms) with campath-1h |
| 06/10/2009 | EP2066351A2 Human antibodies that bind cxcr4 and uses thereof |
| 06/10/2009 | EP2066350A2 Stabilized antibody formulations and uses thereof |
| 06/10/2009 | EP2066349A2 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 06/10/2009 | EP1352070B1 A fibrin/fibrinogen-binding conjugate |
| 06/10/2009 | EP1327147B1 Neurotransmission disorders |
| 06/10/2009 | EP1294899B1 16836, a human phospholipase c family member and uses thereof |
| 06/10/2009 | EP1007570B1 Monospecific antibody reactive with fibrinogen and fibrinopeptide b |
| 06/10/2009 | CN101454347A Influenza antigens, vaccine compositions, and related methods |
| 06/10/2009 | CN101454346A Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 06/10/2009 | CN101454345A High affinity antibodies to human il-6 receptor |
| 06/10/2009 | CN101454344A Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/10/2009 | CN101454343A Modified humanised anti-interleukin-18 antibodies |
| 06/10/2009 | CN101450967A High-purity rabies human immunoglobulin and raw material production method thereof |
| 06/10/2009 | CN100497619C Shingolipid ceramide deacylase gene |
| 06/10/2009 | CN100497610C Polypeptides encoded by human lipase-like gene and composition, and methods of utilizing same |
| 06/10/2009 | CN100497608C Human cholesteryl ester synthetase-2c and its coding sequence |
| 06/10/2009 | CN100497601C Human myeloma cell line |
| 06/10/2009 | CN100497393C Method of detecting precursor with a monoclonal antibody binding to the amino acids 41-46 of brain natriuretic peptide |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497391C Humanized gene engineering antibody resisting hepatitis E virus |
| 06/10/2009 | CN100497390C Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497387C Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497385C Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome |
| 06/10/2009 | CN100497377C SARS coronavirus structure protein ORF3 and its use |
| 06/09/2009 | US7544859 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/09/2009 | US7544790 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544783 Active constituent in antiallergic medicine; block the IgE acceptor; specifically bind to a native IgG inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motif, thereby inhibiting the IgE-driven mediator release from mast cells and basophils |
| 06/09/2009 | US7544782 Tumour necrosis factor binding ligands |
| 06/09/2009 | US7544781 Polypeptide and process for producing the same |
| 06/09/2009 | US7544776 Long wavelength engineered fluorescent proteins |
| 06/09/2009 | US7544774 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
| 06/09/2009 | US7544773 Antimicrobials against pathogenic bacteria and method for screening them |
| 06/09/2009 | US7544771 Identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases; purifying a biological sample and determining amount of protein biomarker |
| 06/09/2009 | US7544767 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544513 Hemoglobin assay for neonatal screening |
| 06/09/2009 | US7544492 Polynucleotide sequences coding human weight regulatory protein; therapy and diagnostic tool for eating disorders, cachexia; gene therapy; modulators of body weight |
| 06/09/2009 | US7544477 Circularly permutated, interaction-activated proteins |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | US7544296 Method and apparatus for separation of milk, colostrum, and whey |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/09/2009 | CA2205118C Dna molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules |
| 06/09/2009 | CA2199408C Herpes simplex virus glycoprotein d variants |
| 06/04/2009 | WO2009070648A2 Humanized anti-amyloid beta antibodies |
| 06/04/2009 | WO2009070642A1 Protein formulation |
| 06/04/2009 | WO2009070294A2 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 06/04/2009 | WO2009070243A2 Wise binding antibodies and epitopes |
| 06/04/2009 | WO2009069916A1 Pharmaceutical formulation comprising hepatitis b virus neutralizing human antibody |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009068649A2 Antigen-binding constructs |
| 06/04/2009 | WO2009068631A1 Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| 06/04/2009 | WO2009068630A1 Immunoglobulin constructs |
| 06/04/2009 | WO2009068628A1 Constructs comprising single variable domains and an fc portion derived from lge. |
| 06/04/2009 | WO2009068627A2 Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| 06/04/2009 | WO2009068625A2 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 06/04/2009 | WO2009068456A1 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (tlx) |
| 06/04/2009 | WO2009068445A1 The present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 06/04/2009 | WO2009068335A1 Human monoclonal nicotine specific antibodies |
| 06/04/2009 | WO2009068282A1 Immunoglobulin aggregates |
| 06/04/2009 | WO2009068204A1 Anti-mesothelin antibodies and uses therefor |
| 06/04/2009 | WO2009067820A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | WO2009067811A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 06/04/2009 | WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof |
| 06/04/2009 | WO2009052439A3 Immunotherapy regimes dependent on apoe status |
| 06/04/2009 | WO2009052081A3 Antibodies that bind il-4 and/or il-13 and their uses |
| 06/04/2009 | WO2009048289A3 Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid |
| 06/04/2009 | WO2009030884A3 Mannosylated butyrophilin tumour markers |
| 06/04/2009 | WO2009006420A3 Vaccine production for pathogenic bird viral diseases |
| 06/04/2009 | WO2008022963A3 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 06/04/2009 | WO2007009065A3 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 06/04/2009 | WO2004063335A3 TNF-α BINDING MOLECULES |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144841 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications |
| 06/04/2009 | US20090143710 Marker for neuromyelitis optica |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143569 Bacteriolytic agent |
| 06/04/2009 | US20090143297 Modulators of antiestrogen pharmacology |